Biomea Fusion Inc.

About Biomea Fusion Inc.

Biomea Fusion is dedicated to revolutionizing medicine by creating therapies that cure patients of serious and life-threatening diseases. They leverage their drug design and operational expertise to develop novel covalent small molecules, which are highly selective and targeted medicines invented in-house. Their R&D engine focuses on all phases of drug discovery and development, from target selection to clinical studies.

Products & Services

Covalent Inhibitor Programs:Three novel programs currently in preclinical and clinical development, focusing on treating serious diseases through highly selective, targeted small molecules.

Specialties

Drug Design Covalent Small Molecules Preclinical and Clinical Development Targeted Medicines for Serious Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 25000000 MR: - FA: approximately $25.0 million FAN: 25000000	D: 2025-10-07 FD: 2025-10-07	2 investors
2	RT: Public Offering T: - FT: Public Offering	A: 40000000 MR: - FA: approximately $40 million FAN: 40000000	D: 2025-06-17 FD: 2025-06-17	1 investors
3	RT: Public Offering T: - FT: Public Offering	A: 172500000 MR: - FA: $172.5 million FAN: 172500000	D: 2023-04-13 FD: 2023-04-13	4 investors
4	RT: Public Offering T: - FT: Public Offering	A: 150000000 MR: - FA: $150.0 million FAN: 150000000	D: 2023-03-29 FD: 2023-03-29	4 investors
5	RT: Public Offering T: - FT: Public Offering	A: 125000000 MR: - FA: $125.0 million FAN: 125000000	D: 2023-03-29 FD: 2023-03-29	4 investors

Public Offering Latest

2025-10-07

$25.0M

2 investors (Pro only)

Public Offering 2025-06-17

$40.0M

Public Offering 2023-04-13

$172.5M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michael "Mick" J.M. Hitchcock

Interim CEO

LinkedIn (Pro only)

R

Ramses Erdtmann

Founder, COO & President

LinkedIn (Pro only)

J

Juan Pablo Frías

Chief Medical Officer

H

Heow Tan

Chief Technical & Quality Officer

N

Naomi Cretcher

Chief People Officer

T

Thorsten Kirschberg

Executive VP, Chemistry

View 57 more team members with Pro

Unlock Full Team Directory

Recent News